Protocol Design Featured Articles
-
A Primer For Understanding Psychedelic Clinical Research
12/11/2023
The emerging field of clinical research on psychedelics brings a unique and transformative approach to CNS drug development. Explore more.
-
Can Data Help Improve Diversity In Clinical Trials?
12/7/2023
Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.
-
Q&A With Novartis And IQVIA Study Start-Up Leaders
12/6/2023
The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines.
-
Identifying Digital Endpoints For Fatigue To Drive Better Clinical Care And Treatments
11/28/2023
The absence of clear biological indicators for fatigue makes diagnosing and finding effective treatments difficult. Cambridge Cognition's Michele Veldsman, Ph.D. is working to develop better biomarkers to improve diagnosis, care, and treatment.
-
Best Practices For Conducting Clinical Trials In Africa
11/21/2023
With its rich ethnic diversity, low trial density, and developing healthcare infrastructures, Africa is poised to become the next frontier of clinical research.
-
How Pfizer Prioritizes Diversity When Implementing Multiple Myeloma Trials
11/21/2023
Every patient deserves the chance to feel seen, heard, and prioritized in research and care — and for Black individuals with multiple myeloma, it’s a matter of urgency.
-
Trial Site Selection And Design Insights For Neurodegenerative Diseases
11/16/2023
Amylyx’s head of global clinical development Lahar Mehta, MD, talks multi-stakeholder trial design, purposeful site selection, the importance of caregiver burden, and the benefits of an open label extension (OLE).
-
China And Japan Encourage Clinical Research By Streamlining Approval
11/15/2023
China and Japan are pivoting themselves as global clinical trial leaders by streamlining their regulatory processes to accelerate drug development and encourage investment.
-
How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?
11/15/2023
Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?
-
“What If” Musings From A 25-Year CRP
11/15/2023
Having been a clinical research professional (CRP) for almost 25 years, Teri Crumb, MSN, RN, CRCC, has seen both operational transformation and stagnation. Here, she looks back — and into the future — asking, "What if?"